We are working at the cutting edge of healthcare analytics. Stay informed here.
AccurKardia joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
The AccurKardia team is excited to join the Innovators’ Network. We are eager to engage with the other network members and the Center, as we pursue our goal of delivering ECG analytics solutions that improve patient outcomes.Read more
Telehealth 2.0: Remote Patient Monitoring Tools to Give Shot in the Arm to Telehealth
Our Co-Founder and CEO, Juan C. Jimenez recently authored an article published by Nasdaq on Telehealth 2.0, discussing how remote patient monitoring tools can give a ‘shot in the arm’ to the virtual care revolution.Read more
Health Tech: Juan Jimenez On How AccurKardia’s Technology Can Make An Important Impact On Our Overall Wellness
In this interview AccurKardia's CEO describes how the Company is improving patients' outcomes and saving lives.Read more
"AccurKardia Announces Collaboration with MDF Instruments to Develop ECG Solutions for the Next Generation of Stethoscopes"
AccurKardia today announced a collaboration with MDF Instruments to develop ECG (electrocardiogram) solutions for the next generation of stethoscopes. This collaboration brings together AccurKardia’s cutting edge innovation in device-agnostic, automated ECG analytics with clinical-grade accuracy and MDF Instruments’ more than 40 years of experience designing, manufacturing, and distributing premium diagnostic instruments.Read more
"BestStartup.us" recognizes AccurKardia in its top picks for the best New York City based Health Diagnostics companies
This article showcases 62 top picks for the best New York City based Health Diagnostics companies. AccurKardia was identified as a cutting edge startup that is taking a variety of approaches to innovating the Health Diagnostics industry.Read more
"Life Science Intelligence" includes AccurKardia in LSI's Medtech Startup Tracker
Life Science Intelligence's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.The AccurKardia platform will be device agnostic and will support automated detection and diagnosis for ambulatory, in-patient telemetry, and consumer ECG devices. As the prevalence of arrhythmia increases in proportion with the growing elderly population, easy-to-use solutions for the detection and diagnostic will become an essential tool to slow the progression of this chronic condition.Read more
Featured on "The Startup Pill's" 101 top picks for the best Health Diagnostics startups in 2021
This article showcases The Startup Pill’s top picks for the best Health Diagnostics startups. Accurkardia was included as one of the 101 companies or start up for its contribution to the healthcare space around the world. AccurKardia was mentioned as an exceptional startups well worth a follow.Read more